Development of curcumin based probe for tau and amyloid imaging

Recently, there has been rising attention in the fluorescence imaging probes of tau fibrils and amyloid beta for the early detection of Alzheimer’s disease (AD). One of the predominant causes of Alzheimer’s disease (AD), is the accumulation of hyper-phosphorylated tau protein forming neurofibrillary...

Full description

Bibliographic Details
Main Author: Satnam Singh
Other Authors: Manojit Pramanik
Format: Thesis
Language:English
Published: 2018
Subjects:
Online Access:http://hdl.handle.net/10356/75261
_version_ 1811691954460688384
author Satnam Singh
author2 Manojit Pramanik
author_facet Manojit Pramanik
Satnam Singh
author_sort Satnam Singh
collection NTU
description Recently, there has been rising attention in the fluorescence imaging probes of tau fibrils and amyloid beta for the early detection of Alzheimer’s disease (AD). One of the predominant causes of Alzheimer’s disease (AD), is the accumulation of hyper-phosphorylated tau protein forming neurofibrillary tangles (NFTs) and accumulation of amyloid beta aggregates which degenerate the neurons. Current research focuses on developing probes to target these aggregates with the help of molecular imaging techniques such as PET, MRI, Optical imaging etc. Despite knowing the pathological phenotypes of the disease and approach on development of fluorescent probes very well, there hasn’t been developed a single test which can diagnose the disease appropriately. Considering the necessity for AD diagnosis, we have synthesized 6 curcumin based fluorescent compounds to screen against tau fibrils and amyloid beta. Curcumin known for its anti-oxidant and anti-inflammatory effect, has also taken a role as a fluorescent probe for detecting tau fibrils and amyloid plaque. Our research also focuses on the development of the in-vitro cell model to test these curcumin derivatives. Hence, we have also aimed to develop in-vitro cell and brain tissue model based on the following two platforms to target the tau and amyloid plaques of AD. i) Transfection of EGFP-Tau-383 (0N4R) isoform into SHSY-5Y cells and showing a co-localization of EGFP with a fluorescent probe of interest, ii) Another platform includes sectioning the brain of a triple transgenic mouse and comparing the tau and amyloid beta targeting ability of fluorescent probe. In this research, we are using reference stains of Thioflavin S and Thioflavin T for standardization purposes. We are aiming to synthesize curcumin derivatives, which will overcome the blood brain barrier and the neuronal cell-membrane permeability factor and allow us to image tau fibrils and amyloid beta plaques, using the in-vitro cell models that we have developed.
first_indexed 2024-10-01T06:28:06Z
format Thesis
id ntu-10356/75261
institution Nanyang Technological University
language English
last_indexed 2024-10-01T06:28:06Z
publishDate 2018
record_format dspace
spelling ntu-10356/752612023-03-03T16:04:31Z Development of curcumin based probe for tau and amyloid imaging Satnam Singh Manojit Pramanik School of Chemical and Biomedical Engineering DRNTU::Engineering::Bioengineering Recently, there has been rising attention in the fluorescence imaging probes of tau fibrils and amyloid beta for the early detection of Alzheimer’s disease (AD). One of the predominant causes of Alzheimer’s disease (AD), is the accumulation of hyper-phosphorylated tau protein forming neurofibrillary tangles (NFTs) and accumulation of amyloid beta aggregates which degenerate the neurons. Current research focuses on developing probes to target these aggregates with the help of molecular imaging techniques such as PET, MRI, Optical imaging etc. Despite knowing the pathological phenotypes of the disease and approach on development of fluorescent probes very well, there hasn’t been developed a single test which can diagnose the disease appropriately. Considering the necessity for AD diagnosis, we have synthesized 6 curcumin based fluorescent compounds to screen against tau fibrils and amyloid beta. Curcumin known for its anti-oxidant and anti-inflammatory effect, has also taken a role as a fluorescent probe for detecting tau fibrils and amyloid plaque. Our research also focuses on the development of the in-vitro cell model to test these curcumin derivatives. Hence, we have also aimed to develop in-vitro cell and brain tissue model based on the following two platforms to target the tau and amyloid plaques of AD. i) Transfection of EGFP-Tau-383 (0N4R) isoform into SHSY-5Y cells and showing a co-localization of EGFP with a fluorescent probe of interest, ii) Another platform includes sectioning the brain of a triple transgenic mouse and comparing the tau and amyloid beta targeting ability of fluorescent probe. In this research, we are using reference stains of Thioflavin S and Thioflavin T for standardization purposes. We are aiming to synthesize curcumin derivatives, which will overcome the blood brain barrier and the neuronal cell-membrane permeability factor and allow us to image tau fibrils and amyloid beta plaques, using the in-vitro cell models that we have developed. ​Master of Science (Biomedical Engineering) 2018-05-30T06:46:27Z 2018-05-30T06:46:27Z 2018 Thesis http://hdl.handle.net/10356/75261 en 54 p. application/pdf
spellingShingle DRNTU::Engineering::Bioengineering
Satnam Singh
Development of curcumin based probe for tau and amyloid imaging
title Development of curcumin based probe for tau and amyloid imaging
title_full Development of curcumin based probe for tau and amyloid imaging
title_fullStr Development of curcumin based probe for tau and amyloid imaging
title_full_unstemmed Development of curcumin based probe for tau and amyloid imaging
title_short Development of curcumin based probe for tau and amyloid imaging
title_sort development of curcumin based probe for tau and amyloid imaging
topic DRNTU::Engineering::Bioengineering
url http://hdl.handle.net/10356/75261
work_keys_str_mv AT satnamsingh developmentofcurcuminbasedprobefortauandamyloidimaging